Clinical Trials Directory

Trials / Completed

CompletedNCT01941589

Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis

Combination Corticosteroids + 5-aminosalicylic Acids Compared to Corticosteroids Alone in the Treatment of Moderate-severe Active Ulcerative Colitis.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
149 (actual)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The role of steroids in the treatment of ulcerative Colitis (UC) is well established, and recommended by professional societies. However, there are no data investigating whether the addition and/or continuation of 5-aminosalicylic agents as combination therapy with systemic corticosteroids is superior to corticosteroids alone in patients with moderate-severe active UC. Thus, in practical terms, the decision regarding 5-aminosalicylic (to add or continue), on top of steroids treatment, is taken on an arbitrary basis. The aim of this study is to compare the efficacy of steroids alone Vs combination of steroids + 5-aminosalicylic in the treatment of moderate-severe UC exacerbation.

Detailed description

he role of steroids in the treatment of ulcerative Colitis (UC) is well established, and recommended by professional societies. However, there are no data investigating whether the addition and/or continuation of 5-aminosalicylic agents as combination therapy with systemic corticosteroids is superior to corticosteroids alone in patients with moderate-severe active UC. Thus, in practical terms, the decision regarding 5-aminosalicylic (to add or continue), on top of steroids treatment, is taken on an arbitrary basis. The aim of this study is to compare the efficacy of steroids alone Vs combination of steroids + 5-aminosalicylic in the treatment of moderate-severe UC exacerbation.

Conditions

Interventions

TypeNameDescription
DRUGoral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolonemaximal oral 5-ASA+/-topical 5-ASA+IV corticosteroids
DRUGcorticosteroids onlyIV corticosteroids only

Timeline

Start date
2013-09-01
Primary completion
2021-04-01
Completion
2021-04-01
First posted
2013-09-13
Last updated
2022-05-09

Locations

10 sites across 7 countries: China, France, Greece, Israel, Italy, Serbia, South Korea

Source: ClinicalTrials.gov record NCT01941589. Inclusion in this directory is not an endorsement.